 | | Counterfeit drugs (WHO/EDM, 1999, 61 p.) |
| | Essential Drugs in Brief No. 1 - 2000 (WHO/DAP - WHO/EDM, 2000, 4 p.) |
| | Essential Drugs in Brief No. 3 - 2001 (WHO/DAP - WHO/EDM, 2001, 4 p.) |
| | Essential Drugs Monitor No. 24 - 1997 (WHO/DAP - WHO/EDM, 1997, 28 p.) |
| | Essential Drugs Monitor No. 25 & 26 - 1998 (WHO/DAP - WHO/EDM, 1998, 36 p.) |
| | Essential Drugs Monitor No. 27 - 1999 (WHO/DAP - WHO/EDM, 1999, 28 p.) |
| | First-year experiences with the Interagency Guidelines for Drug Donations (WHO/EDM, 2000, 51 p.) |
| | General guidelines for methodologies on research and evaluation of traditional medicine (WHO/EDM, 2000, 80 p.) |
| | General principles for guidance in devising International Nonproprietary Names for pharmaceutical substances (WHO/EDM, 25 p.) |
| | Globalization and access to drugs (WHO/EDM, 1999, 97 p.) |
| | Guide to good prescribing: A practical manual (WHO/EDM, 1994, 115 p.) |
| | Guidelines for drug donations: Revised 1999 (Caritas - WCC - ICRC - IFRC - FIP - UNAIDS - MSF - UNHCR - Oxfam - PSF - UNICEF - UNDP - UNFPA - WB - WHO/EDM, 1999, 24 p.) |
| | Guidelines for drug donations: Revised 1999 (In Russian) (Caritas - WCC - ICRC - IFRC - FIP - UNAIDS - MSF - UNHCR - Oxfam - PSF - UNICEF - UNDP - UNFPA - WB - WHO/EDM, 1999, 26 p.) |
| | Guidelines for safe disposal of unwanted pharmaceuticals in and after emergencies (WCC - ECHO - ICRC - IFRC - FIP - ISWA - MSF - UNHCR - Oxfam - PSF - UNICEF - UNDP - WHO/EDM, 1999, 36 p.) |
| | Guidelines for the WHO Review of Dependence-Producing Psychoactive Substances for International Control (WHO/EDM, 2000, 22 p.) |
| | Guidelines on basic training and safety in acupuncture (WHO/EDM, 1999, 35 p.) |
| | Index of pharmacopoeias (WHO/EDM, 2001, 10 p.) |
| | Indicators for monitoring national drug policies (WHO/EDM, 1999, 250 p.) |
| | Narcotic and psychotropic drugs: Achieving balance in national opioids control: Guidelines for assessment (WHO/EDM, 2000, 41 p.) |
| | Operational principles for good pharmaceutical procurement (UNICEF - UNFPA - WB - WHO/EDM, 1999, 32 p.) |
| | Patent situation of HIV/AIDS-related drugs in 80 countries (UNAIDS - WHO/EDM, 2000, 11 p.) |
| | Pharmaceuticals and the WTO TRIPS Agreement: Questions and answers (UNAIDS - WHO/EDM, 2000, 5 p.) |
| | Procedure for the selection of Recommended International Nonproprietary Names for pharmaceutical substances (WHO/EDM, 3 p.) |
| | Reference substances and infrared reference spectra for pharmacopoeial analysis (WHO/EDM, 1999, 117 p.) |
| | WHO Information Exchange System - Alert No. 098 (WHO/EDM, 2000, 1 p.) |
| | WHO Information Exchange System - Alert No. 099 (WHO/EDM, 2000, 1 p.) |
| | WHO Information Exchange System - Alert No. 100 (WHO/EDM, 2000, 1 p.) |
| | WHO Information Exchange System - Alert No. 101 (WHO/EDM, 2001, 1 p.) |
| | WHO Medicines Strategy: Framework for action in essential drugs and medicines policy 2000-2003 (WHO/EDM - WHO/AFRO - WHO/EURO - WHO/SEARO - WHO/AMRO - WHO/EMRO - WHO/WPRO, 2000, 81 p.) |
| | WHO Pharmaceuticals Newsletter No. 1, 2000 (WHO-CCIDM - WHO/EDM, 2000, 18 p.) |
| | WHO Pharmaceuticals Newsletter No. 2, 2000 (WHO-CCIDM - WHO/EDM, 2000, 19 p.) |
| | WHO Pharmaceuticals Newsletter No. 3, 2000 (WHO-CCIDM - WHO/EDM, 2000, 24 p.) |
| | WHO Pharmaceuticals Newsletter No. 4, 2000 (WHO-CCIDM - WHO/EDM, 2000, 22 p.) |
